Does BEVACIZUMAB Cause Interstitial lung disease? 847 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 847 reports of Interstitial lung disease have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 1.1% of all adverse event reports for BEVACIZUMAB.
847
Reports of Interstitial lung disease with BEVACIZUMAB
1.1%
of all BEVACIZUMAB reports
189
Deaths
328
Hospitalizations
How Dangerous Is Interstitial lung disease From BEVACIZUMAB?
Of the 847 reports, 189 (22.3%) resulted in death, 328 (38.7%) required hospitalization, and 40 (4.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 847 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BEVACIZUMAB Alternatives Have Lower Interstitial lung disease Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ